Results 221 to 230 of about 700,142 (373)

“STRANDED ON THE SHORES OF HISTORY”? MONUMENTS AND (ART‐)HISTORICAL AWARENESS

open access: yesHistory and Theory, EarlyView.
ABSTRACT Can past agents deliberately influence our historical awareness by designing objects’ appearances and sending them to us down the stream of time? We know they have certainly tried to do so by raising monuments. But according to an influential narrative, the efforts of the “monumentalists” are destined to fail: no monument can keep a legacy ...
Jakub Stejskal
wiley   +1 more source

Book Review: Cardiovascular Plaque Rupture [PDF]

open access: bronze, 2002
William H. Wehrmacher, Harry L. Messmore
openalex   +1 more source

Offensive Heritage in an Era of Globalization and Mass Migration

open access: yesJournal of Applied Philosophy, EarlyView.
ABSTRACT Essays on the ethics of monuments tend to focus on their morality in relation to domestic populations. In this article we turn our attention to how the principles we favor for the ‘ingroup’ apply to various ‘outgroups’, including foreigners and foreign governments, guest workers, visiting scholars, forcibly annexed or colonized peoples, and ...
Dan Demetriou, Ajume Wingo
wiley   +1 more source

PTRA is useful for renal artery angina by atherosclerotic plaque rupture with unilateral functioning kidney. [PDF]

open access: yesCEN Case Rep, 2022
Morimoto N   +9 more
europepmc   +1 more source

The Role of Plaque Rupture in the Development of Acute Coronary Syndrome Evaluated by the Coronary Angioscope.

open access: bronze, 2000
Kazuhisa Kodama   +4 more
openalex   +1 more source

Coinfection with Mycoplasma Pneumoniae and Chlamydia Pneumoniae in ruptured plaques associated with acute myocardial infarction [PDF]

open access: diamond, 2003
Maria de Lourdes Higuchi   +7 more
openalex   +1 more source

Deucravacitinib in plaque psoriasis: Four‐year safety and efficacy results from the Phase 3 POETYK PSO‐1, PSO‐2 and long‐term extension trials

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In this analysis of the long‐term safety and efficacy of deucravacitinib in patients with moderate to severe plaque psoriasis treated through 4 years, no new safety signals were observed compared with the first year. Patients continuously treated with deucravacitinib from Day 1 maintained clinical and patient‐reported outcome response rates.
April W. Armstrong   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy